PreveCeutical Medical Inc (TSE:PREV)
:PREV
Want to see TSE:PREV full AI Analyst Report?
Total Valuation
PreveCeutical Medical has a market cap or net worth of C$11.74M. The enterprise value is C$16.40M.
Market CapC$11.74M
Enterprise ValueC$16.40M
Share Statistics
PreveCeutical Medical has 586,811,950 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding586,811,950
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
PreveCeutical Medical’s return on equity (ROE) is 0.25 and return on invested capital (ROIC) is 339.03%.
Return on Equity (ROE)0.25
Return on Assets (ROA)-1.09
Return on Invested Capital (ROIC)339.03%
Return on Capital Employed (ROCE)0.59
Revenue Per Employee0.00
Profits Per Employee-226.33K
Employee Count7
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of PreveCeutical Medical is ―. PreveCeutical Medical’s PEG ratio is 0.00.
PE Ratio―
PS Ratio0.00
PB Ratio-2.28
Price to Fair Value-2.28
Price to FCF-8.26
Price to Operating Cash Flow-6.96
PEG Ratio0.00
Income Statement
In the last 12 months, PreveCeutical Medical had revenue of 0.00 and earned -1.58M in profits. Earnings per share was >-0.01.
Revenue0.00
Gross Profit-14.43K
Operating Income-3.37M
Pretax Income-1.69M
Net Income-1.58M
EBITDA-3.35M
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was -1.72M and capital expenditures -60.00K, giving a free cash flow of -1.78M billion.
Operating Cash Flow-1.72M
Free Cash Flow-1.78M
Free Cash Flow per Share>-0.01
Dividends & Yields
PreveCeutical Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.59
52-Week Price Change-33.33%
50-Day Moving Average0.02
200-Day Moving Average0.03
Relative Strength Index (RSI)48.98
Average Volume (3m)143.42K
Important Dates
PreveCeutical Medical upcoming earnings date is Jun 2, 2026, After Close (Confirmed).
Last Earnings DateMay 1, 2026
Next Earnings DateJun 2, 2026
Ex-Dividend Date―
Financial Position
PreveCeutical Medical as a current ratio of 0.15, with Debt / Equity ratio of -74.89%
Current Ratio0.15
Quick Ratio0.15
Debt to Market Cap0.33
Net Debt to EBITDA-1.39
Interest Coverage Ratio-10.44
Taxes
In the past 12 months, PreveCeutical Medical has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
PreveCeutical Medical EV to EBITDA ratio is -5.63, with an EV/FCF ratio of -10.96.
EV to Sales0.00
EV to EBITDA-5.63
EV to Free Cash Flow-10.96
EV to Operating Cash Flow-10.98
Balance Sheet
PreveCeutical Medical has C$10.24K in cash and marketable securities with C$4.68M in debt, giving a net cash position of -C$4.67M billion.
Cash & Marketable SecuritiesC$10.24K
Total DebtC$4.68M
Net Cash-C$4.67M
Net Cash Per Share>-C$0.01
Tangible Book Value Per Share-C$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for PreveCeutical Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-36.36%